Jacques Maydat

Jacques Maydat is an experienced executive in the pharmaceutical industry, currently serving as General Manager of Rare Diseases for France and Benelux at ITALFARMACO S.P.A. since August 2023. Prior to this role, Jacques held multiple leadership positions at EUSA Pharma, including General Manager for Rare Diseases across France, Benelux, and Northern Europe, and at Ipsen, where responsibilities included P&L management and team leadership in oncoendocrinology and other therapeutic areas. Jacques has also contributed to significant roles at Pfizer and Roche, focusing on marketing, sales, and strategy across various medical specialties. Academic qualifications include a PhD in Pharmacy and various executive education programs from INSEAD and HEC School of Business.